Literature DB >> 21499969

Acquisition of a pathogenicity island in an Escherichia coli clinical isolate causing febrile urinary tract infection.

S M Soto1, S Zúñiga, P Ulleryd, J Vila.   

Abstract

Urinary tract infections (UTI) are less common in men than in women, and uropathogenic Escherichia coli (UPEC) is the most frequent etiological agent. Recurrent UTI in men have often been reported as a relapse with the same strain as the index infection. The persistence of the same E. coli strain within the urinary tract has often been explained by a prostatic focus. The aim of this study was to determine whether recurrence was associated with relapse or reinfection and the possible effect of treatment on the content of virulence factors of the isolates causing these infections. Thirty E. coli isolates were collected from 15 patients with a febrile UTI having a bacteriological recurrence during long-term follow-up. These isolates were analyzed by pulsed-field gel electrophoresis (PFGE) and virulence profiling in order to determine whether they constituted relapse or reinfection. Five recurrences were categorized as relapse and nine as reinfections. The results obtained showed that the horizontal transfer of virulence factors contained in a pathogenicity island had occurred in one isolate. This event is possible in vivo and allows bacteria to become more virulent and, perhaps, cause greater damage. The acquisition of virulence genes by horizontal gene transfer is an ongoing process of evolution that continuously leads to new bacterial pathotypes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21499969     DOI: 10.1007/s10096-011-1258-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  27 in total

Review 1.  The chaperone/usher pathway: a major terminal branch of the general secretory pathway.

Authors:  D G Thanassi; E T Saulino; S J Hultgren
Journal:  Curr Opin Microbiol       Date:  1998-04       Impact factor: 7.934

2.  Rapid and simple determination of the Escherichia coli phylogenetic group.

Authors:  O Clermont; S Bonacorsi; E Bingen
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

3.  Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-dependent or -independent pathways, respectively.

Authors:  S M Soto; M T Jimenez de Anta; J Vila
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 4.  Genetics of virulence of enteropathogenic E. coli.

Authors:  J B Kaper; T K McDaniel; K G Jarvis; O Gomez-Duarte
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

5.  Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up.

Authors:  Peter Ulleryd; Torsten Sandberg
Journal:  Scand J Infect Dis       Date:  2003

Review 6.  Urinary tract infections in men. Epidemiology, pathophysiology, diagnosis, and treatment.

Authors:  B A Lipsky
Journal:  Ann Intern Med       Date:  1989-01-15       Impact factor: 25.391

7.  Multiple insertional events, restricted by the genetic background, have led to acquisition of pathogenicity island IIJ96-like domains among Escherichia coli strains of different clinical origins.

Authors:  Philippe Bidet; Stéphane Bonacorsi; Olivier Clermont; Caroline De Montille; Naima Brahimi; Edouard Bingen
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

Review 8.  Pathogenicity islands and the evolution of microbes.

Authors:  J Hacker; J B Kaper
Journal:  Annu Rev Microbiol       Date:  2000       Impact factor: 15.500

9.  Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography.

Authors:  P Ulleryd; B Zackrisson; G Aus; S Bergdahl; J Hugosson; T Sandberg
Journal:  BJU Int       Date:  1999-09       Impact factor: 5.588

10.  Role of capsular colanic acid in adhesion of uropathogenic Escherichia coli.

Authors:  Andrea Hanna; Michael Berg; Valerie Stout; Anneta Razatos
Journal:  Appl Environ Microbiol       Date:  2003-08       Impact factor: 4.792

View more
  5 in total

1.  Multiple antibiotic resistances and virulence markers of uropathogenic Escherichia coli from Mexico.

Authors:  Gloria Luz Paniagua-Contreras; Eric Monroy-Pérez; Areli Bautista; Rogelio Reyes; Andrea Vicente; Felipe Vaca-Paniagua; Clara Estela Díaz; Stephanía Martínez; Pablo Domínguez; Luis Rey García; Alina Uribe-García; Sergio Vaca
Journal:  Pathog Glob Health       Date:  2018-11-15       Impact factor: 2.894

2.  Environmental phosphate differentially affects virulence phenotypes of uropathogenic Escherichia coli isolates causative of prostatitis.

Authors:  M Grillo-Puertas; M G Martínez-Zamora; M R Rintoul; S M Soto; V A Rapisarda
Journal:  Virulence       Date:  2015-06-17       Impact factor: 5.882

3.  Molecular Epidemiology of Antibiotic Resistance Genes and Virulence Factors in Multidrug-Resistant Escherichia coli Isolated from Rodents, Humans, Chicken, and Household Soils in Karatu, Northern Tanzania.

Authors:  Valery Silvery Sonola; Abdul Katakweba; Gerald Misinzo; Mecky Isaac Matee
Journal:  Int J Environ Res Public Health       Date:  2022-04-28       Impact factor: 4.614

4.  The Prevalence of Virulence Genes and Virulotypes of Escherichia coli Strains Isolated from Hospital Wastewaters in Tehran, Iran.

Authors:  Reza Ranjbar; Omid Farahani
Journal:  Iran J Public Health       Date:  2018-05       Impact factor: 1.429

5.  Identification of virulence factors genes in Escherichia coli isolates from women with urinary tract infection in Mexico.

Authors:  Daniela A López-Banda; Erika M Carrillo-Casas; Margarita Leyva-Leyva; Gabriel Orozco-Hoyuela; Ángel H Manjarrez-Hernández; Sara Arroyo-Escalante; David Moncada-Barrón; Silvia Villanueva-Recillas; Juan Xicohtencatl-Cortes; Rigoberto Hernández-Castro
Journal:  Biomed Res Int       Date:  2014-05-05       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.